Syquant Capital’s Amryt Pharma AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-258,000
Closed -$3.76M – 15
2023
Q1
$3.76M Buy
+258,000
New +$3.65M 8.72% 3

Syquant Capital's AMYT Position: Q2 2023 in Review

Syquant Capital sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 258,000 shares — an estimated $3.76M sold.

Syquant Capital first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $3.76M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Syquant Capital reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
  • Syquant Capital sold 258,000 Amryt Pharma shares in Q2 2023, an estimated $3.76M.
  • Syquant Capital first reported a position in Amryt Pharma in Q1 2023 and held it in 1 quarter.
  • Syquant Capital's Amryt Pharma position peaked at $3.76M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.

Based on Syquant Capital's 13F filing for Q2 2023, filed 10 Jul 2023.